• Profile
Close

Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumor in the SIOP WT 2001 trial

European Journal of Cancer Jul 04, 2019

Irtan S, et al. - In order to determine the impact of biopsying Wilms tumor (WT) at diagnosis on assigning the tumor stage and recommended treatment, researchers examined patients treated in the SIOP WT 2001 trial, where needle biopsy was permitted without ‘upstaging’ the tumor to stage III, for the potential association of all types of biopsy with local recurrence. Only open biopsy required treatment as stage III. Four hundred twenty relapsed (139 local) were identified among 2971 patients with unilateral WT (stages I-IV). They identified 969 (33%) patients who underwent biopsy (64% cutting needle, 30% fine needle aspiration and 6% open biopsy). Multivariate analysis comprising all factors associated with local recurrence in univariate analysis revealed only high-risk histology, age≥2 years and preoperative tumor volume as significant. They noted no significant hazard ratio for the association of local recurrence and event-free and overall survival with biopsy. This post hoc analysis suggests no independent adverse effect of needle biopsy on either local recurrence or survival after adjustment for all relevant risk factors. They recommend against using needle biopsy as an automatic criterion to ‘upstage’ WT.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay